Alkem Laboratories Limited (ALKEM.NS)

5.042,00 +36,25 (+0,72%) In data: 11:22AM IST. Mercato aperto.

Alkem Laboratories Limited

Devashish Building
Alkem House Senapati Bapat Road Lower Parel (West)
Mumbai 400013
India
91 22 3982 9999
https://www.alkemlabs.com

Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno: 

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Basudeo Narian Singh	Executive Chairman	192,5M	N/D	1941
Mr. Sarvesh Singh	VP of Sales & Marketing and Executive Director	43,3M	N/D	1981
Mr. Sandeep Derjit Singh	MD & Executive Director	82,7M	N/D	1982
Mr. Mritunjay Kumar Singh	Executive Director	95,9M	N/D	1963
Mr. Srinivas Singh	Executive Director	98,91M	N/D	1989
Ms. Madhurima Singh	Executive Director	94,9M	N/D	1966
Dr. Vikas Gupta	Chief Executive Officer	N/D	N/D	N/D
Mr. Nitin Agrawal	Chief Financial Officer	N/D	N/D	N/D
Mr. Satish Kumar Singh	Head of Operations	N/D	N/D	1960
Ms. Purvi Shah	Head of Investor Relations	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in INR.

Descrizione

Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, dermatology, cardiac, respiratory, gastro-intestinal, central nervous system, urology, and gynaecology, as well as vitamins, minerals, and nutrients; and pain analgesic, anti-diabetic, and neurology products. Alkem Laboratories Limited was incorporated in 1973 and is headquartered in Mumbai, India.

Governance aziendale

L'ISS Governance QualityScore di Alkem Laboratories Limited al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.